Top compounds associated with response to LYSMD1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	PLX4720	CTRPv2	pan-cancer	AAC	-0.0096	0.8
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.0094	0.8
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.0094	0.8
mRNA	QS11	CTRPv2	pan-cancer	AAC	0.02	0.8
mRNA	Sildenafil	CTRPv2	pan-cancer	AAC	-0.01	0.8
mRNA	temsirolimus	GDSC1000	pan-cancer	AAC	0.0088	0.8
mRNA	GSK1059615	CTRPv2	pan-cancer	AAC	-0.012	0.8
mRNA	Docetaxel	gCSI	pan-cancer	AAC	-0.014	0.8
mRNA	PRL-3 Inhibitor I	CTRPv2	pan-cancer	AAC	0.0099	0.8
mRNA	necrostatin-7	CTRPv2	pan-cancer	AAC	0.0095	0.8

Download CSV